An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or prison.
Platform Response and Content Elimination
According to TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The company said it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.
Digital Trading Operations
Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed guides for mixing or administering at home.
Within moments of joining one group, a seller posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Product Details and Costs
Inside these groups, posts show black plastic packages with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it regularly moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already encountered patients injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to possibly serious health risks”.
